Chromatin-bound CRM1 recruits SET-Nup214 and NPM1c onto


Journal

eLife
ISSN: 2050-084X
Titre abrégé: Elife
Pays: England
ID NLM: 101579614

Informations de publication

Date de publication:
22 11 2019
Historique:
received: 11 03 2019
accepted: 30 10 2019
entrez: 23 11 2019
pubmed: 23 11 2019
medline: 19 5 2020
Statut: epublish

Résumé

We previously demonstrated that CRM1, a major nuclear export factor, accumulates at

Identifiants

pubmed: 31755865
doi: 10.7554/eLife.46667
pii: 46667
pmc: PMC6874418
doi:
pii:

Substances chimiques

Chromatin 0
DNA-Binding Proteins 0
Histone Chaperones 0
Homeodomain Proteins 0
Karyopherins 0
NPM1 protein, human 0
NUP214 protein, human 0
Nuclear Export Signals 0
Nuclear Pore Complex Proteins 0
Nuclear Proteins 0
Receptors, Cytoplasmic and Nuclear 0
SET protein, human 0
Nucleophosmin 117896-08-9

Banques de données

GEO
['GSE127983']

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Japan Society for the Promotion of Science
ID : 16K14676
Pays : International
Organisme : Japan Society for the Promotion of Science
ID : 17H03679
Pays : International
Organisme : Japan Society for the Promotion of Science
ID : 25116008
Pays : International
Organisme : Japan Society for the Promotion of Science
ID : 16H04789
Pays : International
Organisme : Japan Society for the Promotion of Science
ID : 19H05244
Pays : International
Organisme : Japan Society for the Promotion of Science
ID : 18H05527
Pays : International
Organisme : Japan Society for the Promotion of Science
ID : 18H04802
Pays : International
Organisme : Japan Society for the Promotion of Science
ID : 17H03608
Pays : International
Organisme : Japan Science and Technology Agency
ID : MJCR16G1
Pays : International

Informations de copyright

© 2019, Oka et al.

Déclaration de conflit d'intérêts

MO, SM, MO, YM, JN, KM, AH, TT, YY, YO No competing interests declared

Références

Elife. 2015 Dec 17;4:
pubmed: 26673895
Leukemia. 2015 Jun;29(6):1279-89
pubmed: 25600023
Elife. 2016 Jan 07;5:e09540
pubmed: 26740045
Cancer Cell. 2018 Sep 10;34(3):499-512.e9
pubmed: 30205049
Leukemia. 2007 Sep;21(9):2000-9
pubmed: 17597811
Cell. 2004 Aug 20;118(4):409-18
pubmed: 15315754
J Biol Chem. 2013 Feb 8;288(6):3952-63
pubmed: 23264634
Genes Cells. 2004 May;9(5):471-7
pubmed: 15147275
Leukemia. 2017 Oct;31(10):2200-2210
pubmed: 28210005
FEBS Lett. 2001 Oct 12;506(3):272-6
pubmed: 11602260
J Biol Chem. 2010 May 21;285(21):16248-57
pubmed: 20233715
J Biol Chem. 2016 Oct 28;291(44):23068-23083
pubmed: 27613868
Genes Cells. 1996 Dec;1(12):1045-56
pubmed: 9077453
Mol Cell Biol. 1999 Sep;19(9):6276-85
pubmed: 10454574
Br J Haematol. 2013 Apr;161(1):117-27
pubmed: 23373539
Cell. 1995 Apr 21;81(2):215-22
pubmed: 7736573
Blood. 2012 Nov 29;120(23):4621-34
pubmed: 23034282
Mol Cell Biol. 2005 Feb;25(4):1258-71
pubmed: 15684379
Mol Cell. 2003 Nov;12(5):1151-64
pubmed: 14636574
Theranostics. 2017 Jun 1;7(8):2289-2304
pubmed: 28740552
Nat Rev Cancer. 2006 Jul;6(7):493-505
pubmed: 16794633
J Biol Chem. 2013 May 24;288(21):15085-97
pubmed: 23580657
Leukemia. 2013 Apr;27(5):1037-43
pubmed: 23183427
Mol Cell Biol. 2016 Jun 15;36(13):1820-35
pubmed: 27114368
Nat Commun. 2016 Jul 28;7:12338
pubmed: 27465542
J Cell Biol. 1997 Jan 27;136(2):241-50
pubmed: 9015297
Mol Cell Biol. 2002 Mar;22(5):1526-36
pubmed: 11839818
Mol Cell Biol. 1992 Apr;12(4):1687-97
pubmed: 1549122
Oncogene. 2007 Oct 15;26(47):6766-76
pubmed: 17934484
Cell Rep. 2015 Oct 27;13(4):690-702
pubmed: 26489467
Cell Rep. 2015 Apr 7;11(1):149-63
pubmed: 25818296
Leukemia. 2015 Feb;29(2):423-32
pubmed: 25027513
Genetics. 2006 Oct;174(2):639-49
pubmed: 16959904
Cell. 2000 Sep 29;103(1):127-40
pubmed: 11051553
Blood. 2017 Oct 26;130(17):1911-1922
pubmed: 28835438
Mol Cell Biol. 2003 Dec;23(23):8528-41
pubmed: 14612398
J Cell Biol. 2017 Jun 5;216(6):1795-1810
pubmed: 28432080
J Virol. 1998 Nov;72(11):8627-35
pubmed: 9765402
J Biol Chem. 2006 Jul 14;281(28):19378-86
pubmed: 16675447
Nat Struct Mol Biol. 2007 Jun;14(6):548-55
pubmed: 17529993
J Cancer. 2013 Sep 10;4(8):614-25
pubmed: 24155773
Mol Cell Biol. 2006 Sep;26(18):6772-85
pubmed: 16943420
Proc Natl Acad Sci U S A. 2007 Mar 13;104(11):4285-90
pubmed: 17360516
Mol Cell Proteomics. 2013 Mar;12(3):664-78
pubmed: 23242554
J Biol Chem. 2011 Aug 19;286(33):29325-35
pubmed: 21708948
Mol Cell Biol. 2005 Jan;25(2):797-807
pubmed: 15632079
J Biol Chem. 1993 May 15;268(14):10582-7
pubmed: 8486711
Blood. 2006 Sep 15;108(6):1999-2005
pubmed: 16720834
Nat Cell Biol. 2007 Jul;9(7):804-12
pubmed: 17589499
J Mol Biol. 2013 Jan 23;425(2):350-64
pubmed: 23164569
Biochem Res Int. 2011;2011:195209
pubmed: 21152184
Cell. 1997 Sep 19;90(6):1051-60
pubmed: 9323133
Blood. 2011 Dec 8;118(24):6247-57
pubmed: 21948299
J Biol Chem. 2004 Jul 16;279(29):30850-5
pubmed: 15136563
Nature. 1997 Nov 20;390(6657):308-11
pubmed: 9384386
Cell. 1997 Sep 19;90(6):1041-50
pubmed: 9323132
Cancer Res. 2006 Mar 15;66(6):3044-50
pubmed: 16540653
Mol Cell Biol. 2008 Dec;28(23):7050-65
pubmed: 18809582
Int J Cancer. 2004 Sep 10;111(4):501-7
pubmed: 15239126
Semin Cell Dev Biol. 2009 Jul;20(5):620-30
pubmed: 19577736
Oncotarget. 2014 Aug 15;5(15):6102-12
pubmed: 25026284
Cancer Res. 2005 Jun 1;65(11):4578-86
pubmed: 15930275
Cell. 1994 Jul 29;78(2):191-201
pubmed: 7913880
J Cell Biol. 1989 Apr;108(4):1195-207
pubmed: 2647765
Science. 1997 Oct 3;278(5335):141-4
pubmed: 9311922
J Clin Invest. 2018 Oct 1;128(10):4260-4279
pubmed: 30015632
Nature. 1987 Mar 19-25;326(6110):292-5
pubmed: 3821905
J Cell Biol. 1999 May 17;145(4):645-57
pubmed: 10330396
Nucleic Acids Res. 2014 Jul;42(Web Server issue):W187-91
pubmed: 24799436
Cancer Res. 2007 Jul 1;67(13):6230-7
pubmed: 17616680
J Cell Biol. 2008 Jul 14;182(1):19-26
pubmed: 18625840
Nat Methods. 2015 Apr;12(4):357-60
pubmed: 25751142
Leukemia. 2014 Jan;28(1):155-65
pubmed: 23588715
Exp Cell Res. 1998 Aug 1;242(2):540-7
pubmed: 9683540
Blood. 2008 May 1;111(9):4668-80
pubmed: 18299449
N Engl J Med. 2005 Jan 20;352(3):254-66
pubmed: 15659725
Dev Biol. 2010 Aug 1;344(1):7-15
pubmed: 20435029
Blood. 2005 Dec 1;106(12):3747-54
pubmed: 16109776
BMC Genomics. 2011 Oct 20;12:516
pubmed: 22011111
Cancer Cell. 2016 Dec 12;30(6):863-878
pubmed: 27889185
Mol Cell Biol. 1992 Aug;12(8):3346-55
pubmed: 1630450
Blood. 2005 Aug 1;106(3):899-902
pubmed: 15831697
Leukemia. 2013 Apr;27(5):1000-8
pubmed: 23212154
Nature. 2009 Apr 30;458(7242):1136-41
pubmed: 19339969
Nucleic Acids Res. 1998 Oct 1;26(19):4508-15
pubmed: 9742256
Blood. 2011 Sep 29;118(13):3645-56
pubmed: 21813447
Mol Biol Cell. 2010 Jun 1;21(11):1885-96
pubmed: 20375145
Oncol Lett. 2014 Sep;8(3):959-962
pubmed: 25120641
Proc Natl Acad Sci U S A. 2013 Jan 22;110(4):1303-8
pubmed: 23297231
J Biol Chem. 1996 May 10;271(19):11059-62
pubmed: 8626647
Mol Cell Biol. 2008 May;28(10):3114-26
pubmed: 18332108
Cells. 2019 Jan 21;8(1):
pubmed: 30669574
Exp Hematol. 2013 Jan;41(1):67-78.e4
pubmed: 22986101
Genetics. 2004 Feb;166(2):895-9
pubmed: 15020474
Cell Cycle. 2005 Nov;4(11):1593-8
pubmed: 16205118

Auteurs

Masahiro Oka (M)

Laboratory of Nuclear Transport Dynamics, National Institutes of Biomedical Innovation, Health and Nutrition (NIBIOHN), Osaka, Japan.
Laboratory of Biomedical Innovation, Graduate School of Pharmaceutical Sciences, Osaka University, Osaka, Japan.

Sonoko Mura (S)

Biomolecular Dynamics Group, Graduate School of Frontier Biosciences, Osaka University, Osaka, Japan.

Mayumi Otani (M)

Laboratory of Nuclear Transport Dynamics, National Institutes of Biomedical Innovation, Health and Nutrition (NIBIOHN), Osaka, Japan.

Yoichi Miyamoto (Y)

Laboratory of Nuclear Transport Dynamics, National Institutes of Biomedical Innovation, Health and Nutrition (NIBIOHN), Osaka, Japan.

Jumpei Nogami (J)

Department of Advanced Medical Initiatives, Faculty of Medicine, Kyushu University, Fukuoka, Japan.

Kazumitsu Maehara (K)

Department of Advanced Medical Initiatives, Faculty of Medicine, Kyushu University, Fukuoka, Japan.

Akihito Harada (A)

Department of Advanced Medical Initiatives, Faculty of Medicine, Kyushu University, Fukuoka, Japan.

Taro Tachibana (T)

Department of Bioengineering, Graduate School of Engineering, Osaka City University, Osaka, Japan.

Yoshihiro Yoneda (Y)

Laboratory of Biomedical Innovation, Graduate School of Pharmaceutical Sciences, Osaka University, Osaka, Japan.
National Institutes of Biomedical Innovation, Health and Nutrition (NIBIOHN), Osaka, Japan.

Yasuyuki Ohkawa (Y)

Department of Advanced Medical Initiatives, Faculty of Medicine, Kyushu University, Fukuoka, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH